CSR

Meda’s Sustainability Reporting

Meda’s Sustainability Report presents how Meda works and performs within areas identified as particularly relevant in a sustainability and business context. Meda has reported in accordance with the Global Reporting Initiative (GRI) since 2010. The information is verified by third party (PwC) and for 2015 Meda reports in accordance with GRI G4, level core.  The Sustainability Report is included in Meda’s Annual Report 2015, pages 41-63.

Meda’s value chain
Meda’s value chain comprises four basic stages;

  • Product portfolio and market development
  • Manufacturing and distribution
  • Sales and marketing
  • Customers and end-users

The relevance, quality, price and availability of the products Meda provides are key attributes to Meda’s business and must be considered at every stage.

  • Patients and consumers
  • Healthcare providers
  • Suppliers
  • Employees
  • Public authorities and agencies
  • Owners/investors
  • Distributors
  • Wholesalers/retailers

Meda works systematically with sustainability matters that are identified as relevant to the company’s business and in relation to prioritized stakeholders. Meda’s sustainability efforts shall be close to the business and support the overall objectives. The work on relevant sustainability matters is about, among other things, to identify risks and opportunities with an impact on the business and to build relationships with key stakeholders.

Meda’s sustainability agenda has four focus areas. They are; 

  • Sustainability governance
  • Operational and environmental efficiency 
  • Responsible new business 
  • Sustainable supply chain 

Some highlights in 2015 were;

  • An anti-corruption policy was issued to complement the Business Conduct Guidelines
  • A Business Partner and Business Ethics Guideline was issued
  • Anti-corruption training was enhanced
  • Meda’s main environmental objective is to reduce carbon emissions per         employee each year.  In 2015 the result was 8.6 ton per employee. That is a reduction compared to 2014.
  • Meda’s ISO 14001-multisite certificate was renewed
  • During 2015, Meda continued to develop the efforts regarding sustainable and responsible supply chain management.

    • The scope of suppliers in Meda’s sustainability follow-up system were expanded and former Rottapharm suppliers are being included.
    • A supplier mapping and a supplier risk mapping was initiated.  The outcome will guide further efforts. 

To set out a relevant sustainability agenda and to fulfill the G4 reporting requirements, Meda performed its second materiality assessment in 2015. This assessment confirmed previous focus areas. However, a slightly greater emphasis on sustainability management in the supply chain, employee development, and business ethics and anti-corruption was highlighted. This is thought to be due to greater general interest in sustainability, more clearly articulated customer expectations and stricter regulations, along with the 2014 acquisition of Rottapharm and Meda’s continued expansion in emerging markets.

More details are presented in the sustainability report 2015. 

This website is intended for people seeking information on Meda AB's Global operations.
We also have national marketing sites. Links to these are under Meda Worldwide at the top of the page.